UHT trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UHT achieves its forward estimates and maintains a stable P/E multiple of 22.6x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 9, 2026, Universal Health Realty Income Trust (UHT) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $543M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, UHT trades at a trailing P/E of 26.9x and forward P/E of 22.6x. Analysts expect EPS to grow +24.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $59.66, with bear and bull scenarios of $37.59 and $78.61 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HRHealthcare Realty Trust Incorporated | $6.7B | $19.20 | $22.00 | +14.6% | Hold | — | 30 |
 CHCTCommunity Healthcare Trust Incorporated | $420M | $14.71 | $17.00 | +15.6% | Hold | 40.9x | 16 |
 XRNChiron Real Estate Inc. | $380M | $28.70 | $20.92 | -37.1% | Buy | 554.0x | 22 |
 NTSTNETSTREIT Corp. | $2.0B | $18.80 | $22.33 | +18.8% | Buy | 60.3x | 19 |
 PLTKPlaytika Holding Corp. | $928M | $2.44 | $3.44 | +41.0% | Hold | 7.8x | 17 |
 VTRVentas, Inc. | $43.1B | $88.75 | $99.08 | +11.6% | Buy | 155.0x | 32 |
 WELLWelltower Inc. | $176.5B | $245.01 | $261.17 | +6.6% | Buy | 86.7x | 37 |
 OHIOmega Healthcare Investors, Inc. | $14.4B | $48.19 | $49.43 | +2.6% | Hold | 18.2x | 29 |
 MPTMedical Properties Trust, Inc. | $1.1B | $1.81 | $2.25 | -59.1% | Hold | 48.1x | 28 |
 LTCLTC Properties, Inc. | $2.3B | $44.77 | $50.00 | +11.7% | Hold | 19.9x | 22 |
Quick answers to the most common questions about buying UHT stock.
The consensus price target for UHT is $N/A, close to the current price of $39.11 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
UHT has a consensus rating of "Hold" based on 1 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
UHT trades at a forward P/E of 22.6069x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $N/A for UHT, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $79 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UHT is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UHT stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $60, with bear/bull scenarios of $38/$79.
Our quantitative valuation model calculates UHT's fair value at $60 (base case), with a bear case of $38 and bull case of $79. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
UHT trades at a forward P/E ratio of 22.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 26.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
UHT appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UHT analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $38-$79 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.